Lecturer of the Department of Biochemistry and Molecular Biology and researcher of the Neurosciences Institute. He has lead a study that describes a new mechanism of anti-tumour action, discovered during the development of the drug ABTL0812. Published in Clinical Cancer Research, the new drug enhances the effect of standard chemotherapies.
Area of Communication & Promotion
08193 Bellaterra (Cerdanyola del Vallès)